Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
China flag China · Delayed Price · Currency is CNY
69.22
+0.30 (0.44%)
At close: Nov 13, 2026

SHA:688198 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
650.56617.78500.26369.91295.07251.8
Other Revenue
2.372.371.610.730.10.02
652.93620.15501.88370.64295.17251.82
Revenue Growth
10.43%23.57%35.41%25.57%17.21%38.42%
Cost of Revenue
70.3667.0958.5237.6431.3629.61
Gross Profit
582.57553.06443.35333263.81222.21
Selling, General & Admin
227.35202.29154.92131.97123.77131.16
Research & Development
156.92155.33151.4498.8155.1558.9
Other Operating Expenses
29.446.692.731.251.621.17
Operating Expenses
414.95366.46311.49233.5181.64192.04
Operating Income
167.61186.6131.8699.582.1730.17
Interest Expense
-0.53-1.44-0.46-0.41-0.08-0.12
Interest & Investment Income
6.6210.6217.3217.6622.5316.49
Currency Exchange Gain (Loss)
-1.07-1.070.05-0.260-
Other Non Operating Income (Expenses)
-2.04-0.59-0.16-0.06-0.68-0.05
EBT Excluding Unusual Items
170.6194.11148.62116.43103.9446.5
Gain (Loss) on Sale of Investments
0.640.830.7410.890.97
Gain (Loss) on Sale of Assets
-0.06-0-0.050.05-0.01-0.02
Other Unusual Items
27.3911.191.482.541.322.31
Pretax Income
198.57206.13150.79120.02106.1449.76
Income Tax Expense
25.8326.4518.6410.6111.74-1.51
Earnings From Continuing Operations
172.75179.68132.14109.4194.3951.26
Minority Interest in Earnings
4.6813.8914.195.80.73-0.06
Net Income
177.43193.57146.33115.2195.1351.2
Net Income to Common
177.43193.57146.33115.2195.1351.2
Net Income Growth
-1.61%32.28%27.02%21.11%85.80%-9.42%
Shares Outstanding (Basic)
136137137136136135
Shares Outstanding (Diluted)
136137137137136135
Shares Change
-1.52%0.39%-0.29%0.92%0.86%0.44%
EPS (Basic)
1.301.411.070.850.700.38
EPS (Diluted)
1.301.411.070.840.700.38
EPS Growth
-0.09%31.78%27.38%20.00%84.21%-9.82%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
13.4161.6-27.0212.5324.014.27
Free Cash Flow Per Share
0.100.45-0.200.090.180.03
Dividend Per Share
0.8000.8000.8000.8000.5000.357
Dividend Growth
0%0%0%60.00%40.02%149.90%
Gross Margin
89.22%89.18%88.34%89.84%89.38%88.24%
Operating Margin
25.67%30.09%26.27%26.85%27.84%11.98%
Profit Margin
27.17%31.21%29.16%31.08%32.23%20.33%
Free Cash Flow Margin
2.05%9.93%-5.38%3.38%8.14%1.70%
EBITDA
219.54224.73151.61110.787.7836.19
EBITDA Margin
33.62%36.24%30.21%29.87%29.74%14.37%
D&A For EBITDA
51.9338.1419.7511.195.616.02
EBIT
167.61186.6131.8699.582.1730.17
EBIT Margin
25.67%30.09%26.27%26.85%27.84%11.98%
Effective Tax Rate
13.01%12.83%12.36%8.84%11.06%-
Revenue as Reported
238.43620.15501.88370.64295.17251.82
Advertising Expenses
-6.662.010.371.121.22